The warm autoimmune hemolytic anemia market is growing, driven by development of complement inhibitors, monoclonal antibodies, and therapies targeting autoimmune destruction of red blood cells. https://www.datamintelligence.com/research-report/warm-autoimmune-hemolytic-anemia-market